Iradimed (IRMD) Equity Ratio (2013 - 2026)

Iradimed (IRMD) has 14 years of Equity Ratio data on file, last reported at 0.86 in Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.86, down 2.71% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.86 (down 2.71% YoY), and the FY2025 annual result was 0.87, down 1.49% from the prior year.
• Equity Ratio slipped to 0.86 in Q1 2026 per IRMD's latest filing, from 0.87 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.89 in Q2 2025 and troughed at 0.77 in Q4 2023.
• A 5-year average of 0.86 and a median of 0.86 in 2024 frame the typical range for Equity Ratio.
• The sharpest annual moves came in 2023 and 2024: Equity Ratio declined 10.05% in 2023, then grew 13.93% in 2024.
• A 5-year view of Equity Ratio shows it stood at 0.86 in 2022, then decreased by 10.05% to 0.77 in 2023, then climbed by 13.93% to 0.88 in 2024, then dropped by 1.49% to 0.87 in 2025, then dropped by 0.99% to 0.86 in 2026.
• Business Quant data shows IRMD's Equity Ratio at 0.86 in Q1 2026, 0.87 in Q4 2025, and 0.86 in Q3 2025.